Chrysoula Leontiou Dr Richard Quinton
| The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas | 2008 |
|
Kathryn Gilroy Chrysoula Leontiou Dr Kay Padget Professor Jeremy Lakey Professor Caroline Austin et al. | mAMSA resistant human topoisomerase IIβ mutation G465D has reduced ATP hydrolysis activity | 2006 |
|
Chrysoula Leontiou Professor Jeremy Lakey Professor Robert Lightowlers Professor Caroline Austin
| Mutation P732L in human DNA topoisomerase II abolishes DNA cleavage in the presence of calcium and confers drug resistance | 2006 |
|
Fiona Errington Dr Elaine Willmore Chrysoula Leontiou Dr Michael Tilby Professor Caroline Austin et al. | Differences in the longevity of topo IIα and topo IIβ drug-stabilized cleavable complexes and the relationship to drug sensitivity | 2004 |
|
Chrysoula Leontiou Kathryn Gilroy Gary Watters Professor Caroline Austin
| Identifying drug-resistant mutations in human topoisomerase II beta using a forced molecular evolution approach | 2004 |
|
Chrysoula Leontiou Professor Jeremy Lakey Professor Caroline Austin
| Mutation E522K in human DNA topoisomerase IIβ confers resistance to methyl N-(4′-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4′-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposide | 2004 |
|
Chrysoula Leontiou Professor Robert Lightowlers Professor Jeremy Lakey Professor Caroline Austin
| Kinetic analysis of human topoisomerase IIα and β DNA binding by surface plasmon resonance | 2003 |
|